Yamaguchi Masato, Sugimoto Koji, Tsukube Takuro, Mori Takeki, Kawahira Toshihiro, Hayashi Taro, Nakamura Masahiko, Kawasaki Ryota, Sandhu Rajdeep S, Sugimura Kazuro, Kozawa Syuichi, Okita Yutaka
Department of Radiology, Kobe Red Cross Hospital/Hyogo Emergency Medical Center, Kobe, Japan.
Ann Thorac Surg. 2008 Sep;86(3):780-6. doi: 10.1016/j.athoracsur.2008.05.040.
Blunt trauma-induced aortic injury traditionally has been treated with early open surgical repair. However, recently endovascular stent-graft technology is considered a less-invasive therapeutic alternative, and flexible stent-grafts, such as the Matsui-Kitamura stent-graft (MKSG), are being used widely. We report our experience with the curved MKSG in treating thoracic aortic injuries.
Nine patients with traumatic thoracic aortic injury underwent endovascular surgery (8, emergency; 1, elective) with curved MKSG. The study variables were Injury Severity Score, endovascular surgery duration, aortic and stent-graft diameter, stay in the intensive care unit, follow-up period, and mortality. An MKSG was constructed using the Matsui-Kitamura stent and a polyester fabric graft. The stent-graft was placed using the transfemoral approach and the wire-tug technique.
The mean Injury Severity Score was 42.3; 5 patients required 6 emergency procedures before the endovascular procedure (pneumothorax or hemothorax drainage, 5; transarterial embolization, 1). In 8 patients (88.9%), we achieved complete pseudoaneurysm exclusion or hemostasis in the injured portion. There were no postoperative complications; blood loss was minimal, and the intensive care unit stay was 13.4 days. The overall hospital mortality was 22.2% (n = 2; causes of death were unrelated to MKSG placement). Neither intervention-related mortality during follow-up (mean, 237.7 days) nor late endovascular graft-related complications (endoleak or graft migration) were noted.
Although this study is limited by a small sample size and short follow-up period, no collapse or stent-graft fractures were noted. Thus, MKSG placement for traumatic thoracic aortic injury appears a safe and effective therapy.
钝性创伤所致主动脉损伤传统上采用早期开放手术修复治疗。然而,近来血管内支架移植物技术被认为是一种侵入性较小的治疗选择,诸如松井 - 北村支架移植物(MKSG)之类的可弯曲支架移植物正得到广泛应用。我们报告了使用弯曲MKSG治疗胸主动脉损伤的经验。
9例创伤性胸主动脉损伤患者接受了使用弯曲MKSG的血管内手术(8例为急诊手术;1例为择期手术)。研究变量包括损伤严重度评分、血管内手术持续时间、主动脉及支架移植物直径、重症监护病房停留时间、随访期及死亡率。MKSG采用松井 - 北村支架和聚酯纤维织物移植物构建而成。支架移植物通过经股动脉途径及导丝牵拉技术置入。
平均损伤严重度评分为42.3;5例患者在血管内手术前需要进行6次急诊手术(气胸或血胸引流,5次;经动脉栓塞,1次)。8例患者(88.9%)实现了受伤部位假性动脉瘤的完全封堵或止血。无术后并发症;失血量极少,重症监护病房停留时间为13.4天。总体医院死亡率为22.2%(n = 2;死亡原因与MKSG置入无关)。随访期间(平均237.7天)未发现与干预相关的死亡,也未发现晚期血管内移植物相关并发症(内漏或移植物移位)。
尽管本研究受样本量小和随访期短的限制,但未发现塌陷或支架移植物断裂情况。因此,MKSG置入治疗创伤性胸主动脉损伤似乎是一种安全有效的治疗方法。